- Home
- EVAX vs IMCC Comparison
EVAX vs IMCC Comparison
Compare EVAX & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- IMCC
- Stock Information
- Founded
- EVAX 2008
- IMCC 1980
- Country
- EVAX Denmark
- IMCC Israel
- Employees
- EVAX N/A
- IMCC N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- EVAX Health Care
- IMCC Health Care
- Exchange
- EVAX Nasdaq
- IMCC Nasdaq
- Market Cap
- EVAX 17.8M
- IMCC 12.2M
- IPO Year
- EVAX 2021
- IMCC N/A
- Fundamental
- Price
- EVAX $2.94
- IMCC $1.96
- Analyst Decision
- EVAX Strong Buy
- IMCC
- Analyst Count
- EVAX 2
- IMCC 0
- Target Price
- EVAX $10.00
- IMCC N/A
- AVG Volume (30 Days)
- EVAX 71.6K
- IMCC 68.9K
- Earning Date
- EVAX 10-30-2025
- IMCC 11-13-2025
- Dividend Yield
- EVAX N/A
- IMCC N/A
- EPS Growth
- EVAX N/A
- IMCC N/A
- EPS
- EVAX N/A
- IMCC N/A
- Revenue
- EVAX $3,176,000.00
- IMCC $38,430,631.00
- Revenue This Year
- EVAX N/A
- IMCC $47.12
- Revenue Next Year
- EVAX $425.50
- IMCC $12.83
- P/E Ratio
- EVAX N/A
- IMCC N/A
- Revenue Growth
- EVAX 1042.45
- IMCC 5.08
- 52 Week Low
- EVAX $1.20
- IMCC $1.29
- 52 Week High
- EVAX $17.20
- IMCC $7.12
- Technical
- Relative Strength Index (RSI)
- EVAX 52.53
- IMCC 48.61
- Support Level
- EVAX $2.81
- IMCC N/A
- Resistance Level
- EVAX $3.04
- IMCC $2.03
- Average True Range (ATR)
- EVAX 0.20
- IMCC 0.24
- MACD
- EVAX -0.01
- IMCC -0.07
- Stochastic Oscillator
- EVAX 71.19
- IMCC 75.04
About EVAX Evaxion Biotech
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.